Ceribell Projects 2026 Revenue Growth Following CMS Reimbursement Decision
Ceribell forecasts 2026 revenue between $114M-$117M after CMS finalized a new technology payment of up to $2,171 per patient.
Read the full storyInficon raised its 2026 financial guidance on July 30, driven by strong demand momentum in the semiconductor sector. On August 5, Bed Bath & Beyond announced Q3 revenue expectations between $505M and $525M, a 30% gross margin target, and a planned transition to the NASDAQ exchange under the ticker NXH. Additionally, SBM Offshore increased its 2026 guidance on August 6 following a robust performance in the first half of the year.
Ceribell forecasts 2026 revenue between $114M-$117M after CMS finalized a new technology payment of up to $2,171 per patient.
Read the full storyThe REIT increased its full-year 2026 FFOAA guidance to $5.41–$5.57 per share after reporting double-digit year-over-year growth in key financial metrics.
The energy services firm upgraded its 2026 financial outlook citing robust operational results and strong execution during the first half of the year.
The retailer targets a 30% gross margin for Q3 while seeking to transition its stock listing to NASDAQ under the new ticker NXH.
Inficon upgraded its 2026 financial outlook, citing sustained momentum and high investment levels in the global semiconductor manufacturing industry.